These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29296556)

  • 1. Rapid resolution of stromal keratitis with the assistance of oral voriconazole in resistant acanthamoeba keratitis.
    Hou TY; Chen YC; Hsu CC
    Taiwan J Ophthalmol; 2017; 7(4):224-226. PubMed ID: 29296556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of chronic stromal acanthamoeba keratitis with oral voriconazole monotherapy.
    Tu EY; Joslin CE; Shoff ME
    Cornea; 2010 Sep; 29(9):1066-8. PubMed ID: 20539217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with voriconazole in 3 eyes with resistant Acanthamoeba keratitis.
    Bang S; Edell E; Eghrari AO; Gottsch JD
    Am J Ophthalmol; 2010 Jan; 149(1):66-9. PubMed ID: 19875089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of voriconazole anti-Acanthamoeba polyphaga in vitro activity, rat cornea penetration and efficacy against experimental rat Acanthamoeba keratitis.
    Gueudry J; Le Goff L; Compagnon P; Lefevre S; Colasse E; Aknine C; Duval F; François A; Razakandrainibe R; Ballet JJ; Muraine M; Favennec L
    J Antimicrob Chemother; 2018 Jul; 73(7):1895-1898. PubMed ID: 29596605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the in vitro activity of commercially available moxifloxacin and voriconazole eye-drops against clinical strains of Acanthamoeba.
    Martín-Navarro CM; López-Arencibia A; Arnalich-Montiel F; Valladares B; Piñero JE; Lorenzo-Morales J
    Graefes Arch Clin Exp Ophthalmol; 2013 Sep; 251(9):2111-7. PubMed ID: 23686225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Alternaria keratitis with intrastromal and topical caspofungin in combination with intrastromal, topical, and oral voriconazole.
    Neoh CF; Leung L; Vajpayee RB; Stewart K; Kong DC
    Ann Pharmacother; 2011 May; 45(5):e24. PubMed ID: 21521864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful use of topical voriconazole 1% alone as first-line antifungal therapy against Candida albicans keratitis.
    Al-Badriyeh D; Leung L; Davies GE; Stewart K; Kong D
    Ann Pharmacother; 2009 Dec; 43(12):2103-7. PubMed ID: 19861430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acanthamoeba keratitis in Mexico: Report of a clinical case and importance of sensitivity assays for a better outcome.
    Omaña-Molina M; Vanzzini-Zago V; Hernández-Martínez D; Reyes-Batlle M; Castelan-Ramírez I; Hernández-Olmos P; Salazar-Villatoro L; González-Robles A; Ramírez-Flores E; Servín-Flores C; Flores-Alvarado V; Alcántara-Castro M; Lorenzo-Morales J
    Exp Parasitol; 2019 Jan; 196():22-27. PubMed ID: 30472333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendrite-like anterior stromal keratitis coinfected with
    Hsu CC
    Taiwan J Ophthalmol; 2019; 9(2):131-133. PubMed ID: 31198674
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful salvage treatment of Scedosporium apiospermum keratitis with topical voriconazole after failure of natamycin.
    Al-Badriyeh D; Leung L; Davies GE; Stewart K; Kong D
    Ann Pharmacother; 2009 Jun; 43(6):1139-42. PubMed ID: 19435962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsporidial Stromal Keratitis: Successful Treatment with Topical Voriconazole and Oral Itraconazole.
    Coca M; Kim J; Shenoy S; Chévez-Barrios P; Kapur M
    Cureus; 2016 Dec; 8(12):e934. PubMed ID: 28123915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized masked pilot clinical trial to compare the efficacy of topical 1% voriconazole ophthalmic solution as monotherapy with combination therapy of topical 0.02% polyhexamethylene biguanide and 0.02% chlorhexidine in the treatment of Acanthamoeba keratitis.
    Bagga B; Sharma S; Gour RPS; Mohamed A; Joseph J; M Rathi V; Garg P
    Eye (Lond); 2021 May; 35(5):1326-1333. PubMed ID: 32719525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acanthamoeba keratitis: a parasite on the rise.
    Thebpatiphat N; Hammersmith KM; Rocha FN; Rapuano CJ; Ayres BD; Laibson PR; Eagle RC; Cohen EJ
    Cornea; 2007 Jul; 26(6):701-6. PubMed ID: 17592320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presumed late recurrence of Acanthamoeba keratitis exacerbated by exposure to topical corticosteroids.
    Patel DV; McGhee CNj
    Oman J Ophthalmol; 2013 Sep; 6(Suppl 1):S40-2. PubMed ID: 24391372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive Oral Voriconazole Treatment of Fusarium Keratitis: A Secondary Analysis From the Mycotic Ulcer Treatment Trial II.
    Prajna NV; Krishnan T; Rajaraman R; Patel S; Shah R; Srinivasan M; Devi L; Das M; Ray KJ; O'Brien KS; Oldenburg CE; McLeod SD; Zegans ME; Acharya NR; Lietman TM; Rose-Nussbaumer J;
    JAMA Ophthalmol; 2017 Jun; 135(6):520-525. PubMed ID: 28426856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Penetrating Keratoplasty À Chaud May Improve Outcome in Therapy-Resistant Acanthamoeba Keratitis.
    Laurik KL; Szentmáry N; Daas L; Langenbucher A; Seitz B
    Adv Ther; 2019 Sep; 36(9):2528-2540. PubMed ID: 31317392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical interventions for fungal keratitis.
    FlorCruz NV; Evans JR
    Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD004241. PubMed ID: 25855311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voriconazole in the management of Alternaria keratitis.
    Ozbek Z; Kang S; Sivalingam J; Rapuano CJ; Cohen EJ; Hammersmith KM
    Cornea; 2006 Feb; 25(2):242-4. PubMed ID: 16371794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acanthamoeba keratitis: about the first two Tunisian cases].
    Ben Salah S; Makni F; Cheikrouhou F; Ben Zina Z; Mlik M; Feki J; Colin J; Ayadi A
    Bull Soc Pathol Exot; 2007 Feb; 100(1):41-2. PubMed ID: 17402694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro development of an effective treatment for Acanthamoeba keratitis.
    Ortillés Á; Belloc J; Rubio E; Fernández MT; Benito M; Cristóbal JÁ; Calvo B; Goñi P
    Int J Antimicrob Agents; 2017 Sep; 50(3):325-333. PubMed ID: 28709990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.